Disseminated tuberculosis in a child during the COVID-19 pandemic : a case report and literature review
Copyright © 2023 Weng, Dong, Huang, Zhao, Zhang, Cao, Tang, Zhang and Zhang..
Background: Disseminated tuberculosis is an uncommon but devastating form of tuberculosis, possibly developing with the immune response of patients. COVID-19 infection may produce an immunosuppressive effect with possible implications for tuberculosis dissemination.
Case presentation: A 17-year-old female patient with a history of tuberculous pleurisy presented to the hospital with a high fever and life-threatening dyspnea after contracting a COVID-19 infection. Her condition deteriorated rapidly with grand mal epilepsy and acute gastrointestinal bleeding with a grossly depressed CD4 T-cell count, which was indicative of her profoundly immunosuppressed state. After identifying Mycobacterium tuberculosis in her cerebrospinal fluid and a subcutaneous abscess in her left lower back, she was diagnosed with disseminated tuberculosis involving both lungs, the central nervous system, the terminal ileum, the liver, bilateral adnexal tissue, and subcutaneous soft tissue in accordance with the chest and abdominal CT. Empirical treatment was initiated with dexamethasone (5 mg/day) and an anti-tuberculosis regimen of isoniazid, rifampicin, pyrazinamide, amikacin, and meropenem, which was replaced with faropenem after she left the hospital. The therapeutic effect was considered satisfied in the second month of follow-up.
Conclusion: To the best of our knowledge, we report the first case report of disseminated tuberculosis after COVID-19 infection. Tuberculosis may disseminate and progress during the COVID-19 pandemic, requiring more significant studies to provide better diagnosis and treatment options for the co-infection.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:14 |
---|---|
Enthalten in: |
Frontiers in immunology - 14(2023) vom: 19., Seite 1249878 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Weng, Taoping [VerfasserIn] |
---|
Links: |
---|
Themen: |
COVID-19 |
---|
Anmerkungen: |
Date Completed 03.10.2023 Date Revised 03.10.2023 published: Electronic-eCollection Citation Status MEDLINE |
---|
doi: |
10.3389/fimmu.2023.1249878 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM362772371 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM362772371 | ||
003 | DE-627 | ||
005 | 20231226210955.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.3389/fimmu.2023.1249878 |2 doi | |
028 | 5 | 2 | |a pubmed24n1209.xml |
035 | |a (DE-627)NLM362772371 | ||
035 | |a (NLM)37781385 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Weng, Taoping |e verfasserin |4 aut | |
245 | 1 | 0 | |a Disseminated tuberculosis in a child during the COVID-19 pandemic |b a case report and literature review |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 03.10.2023 | ||
500 | |a Date Revised 03.10.2023 | ||
500 | |a published: Electronic-eCollection | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2023 Weng, Dong, Huang, Zhao, Zhang, Cao, Tang, Zhang and Zhang. | ||
520 | |a Background: Disseminated tuberculosis is an uncommon but devastating form of tuberculosis, possibly developing with the immune response of patients. COVID-19 infection may produce an immunosuppressive effect with possible implications for tuberculosis dissemination | ||
520 | |a Case presentation: A 17-year-old female patient with a history of tuberculous pleurisy presented to the hospital with a high fever and life-threatening dyspnea after contracting a COVID-19 infection. Her condition deteriorated rapidly with grand mal epilepsy and acute gastrointestinal bleeding with a grossly depressed CD4 T-cell count, which was indicative of her profoundly immunosuppressed state. After identifying Mycobacterium tuberculosis in her cerebrospinal fluid and a subcutaneous abscess in her left lower back, she was diagnosed with disseminated tuberculosis involving both lungs, the central nervous system, the terminal ileum, the liver, bilateral adnexal tissue, and subcutaneous soft tissue in accordance with the chest and abdominal CT. Empirical treatment was initiated with dexamethasone (5 mg/day) and an anti-tuberculosis regimen of isoniazid, rifampicin, pyrazinamide, amikacin, and meropenem, which was replaced with faropenem after she left the hospital. The therapeutic effect was considered satisfied in the second month of follow-up | ||
520 | |a Conclusion: To the best of our knowledge, we report the first case report of disseminated tuberculosis after COVID-19 infection. Tuberculosis may disseminate and progress during the COVID-19 pandemic, requiring more significant studies to provide better diagnosis and treatment options for the co-infection | ||
650 | 4 | |a Review | |
650 | 4 | |a Case Reports | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 4 | |a COVID-19 | |
650 | 4 | |a case report | |
650 | 4 | |a disseminated tuberculosis | |
650 | 4 | |a immunosuppression | |
650 | 4 | |a treatment | |
650 | 4 | |a tuberculosis | |
650 | 7 | |a Isoniazid |2 NLM | |
650 | 7 | |a V83O1VOZ8L |2 NLM | |
700 | 1 | |a Dong, Yaqiong |e verfasserin |4 aut | |
700 | 1 | |a Huang, Niwen |e verfasserin |4 aut | |
700 | 1 | |a Zhao, Chenqu |e verfasserin |4 aut | |
700 | 1 | |a Zhang, Lei |e verfasserin |4 aut | |
700 | 1 | |a Cao, Shan |e verfasserin |4 aut | |
700 | 1 | |a Tang, Jing |e verfasserin |4 aut | |
700 | 1 | |a Zhang, Danni |e verfasserin |4 aut | |
700 | 1 | |a Zhang, Xianming |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Frontiers in immunology |d 2010 |g 14(2023) vom: 19., Seite 1249878 |w (DE-627)NLM215811453 |x 1664-3224 |7 nnns |
773 | 1 | 8 | |g volume:14 |g year:2023 |g day:19 |g pages:1249878 |
856 | 4 | 0 | |u http://dx.doi.org/10.3389/fimmu.2023.1249878 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 14 |j 2023 |b 19 |h 1249878 |